Do genetic polymorphisms influence imatinib trough concentrations in patients with chronic myeloid leukemia? A systematic review and meta-analysis.

Saved in:
Bibliographic Details
Title: Do genetic polymorphisms influence imatinib trough concentrations in patients with chronic myeloid leukemia? A systematic review and meta-analysis.
Authors: de Moraes FCA; Department of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of Sao Paulo, Sao Paulo, Brazil., Matheus GTFU; Department of Medicine, Federal University of Triângulo Mineiro, Uberaba, Brazil., Rego LHRM; Department of Medicine, State University of Piauí, Teresina, Brazil., Sano VKT; Department of Medicine, Federal University of Acre, Rio Branco, Brazil., Gazabón JB; Department of Medicine, Federal University of Rio Grande do Sul, Porto Alegre, Brazil., Burbano RMR; Teaching and Research Department, Ophir Loyola Hospital, Belém, Brazil.
Source: Expert review of anticancer therapy [Expert Rev Anticancer Ther] 2026 May; Vol. 26 (5), pp. 629-638. Date of Electronic Publication: 2025 Dec 16.
Publication Type: Journal Article; Meta-Analysis; Systematic Review; Review
Journal Info: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101123358 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8328 (Electronic) Linking ISSN: 14737140 NLM ISO Abbreviation: Expert Rev Anticancer Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1744-8328
DOI:10.1080/14737140.2025.2602802